Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds

The controversial diabetes drug Avandia does raise the risk of heart attack more than other medications of its kind but

Read more

FDA Bars New Patients From Joining Study of Diabetes Drug Tied to Heart Risks | Pharmaceutical Proce

U.S. federal health officials are barring new patients from enrolling in a safety study of GlaxoSmithKline’s controversial diabetes pill Avandia,

Read more